ArticleInfluenza and other respiratory viruses2024

Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection-Increasing Community Access to Testing Program, United States, January-September 2023.

Allison Avrich Ciesla et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.